Weekly News

Venture Category: Biotechnology

This week's biotechnology venture startup news

Acer Therapeutics - Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders
NEWTON, MA – Dec. 22, 2020 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced full enrollment of its p...
    Argonaut Manufacturing Services - Best of Argonaut in 2020
    With a loaded 2020, it was easy to miss events close to [...]
    The post Best of Argonaut in 2020 appeared first on Argonaut Manufacturing.
      AxoSim - Fabrication and Characterization of 3D Printed, 3D Microelectrode Arrays for Interfacing with a Peripheral Nerve-on-a-Chip
      December 10, 2020 We present a nontraditional fabrication technique for the realization of three-dimensional (3D) microelectrode arrays (MEAs) capable of interfacing with 3D cellular networks in vitro. The technology uses cost-effective makerspace microfabrication techniques to fabricate the 3...
        Benson Hill - (Seed World) New Markets Offer Partnerships says Matt Crisp
        Seed World discusses with Matt Crisp the opportunities of high protein soybean, and how it’s encouraged new growth and partnerships with Benson Hill. Take a listen here. 
        The post 
          BioSapien Inc - The Conduct Science Podcast: The Science of Christmas
          The post The Conduct Science Podcast: The Science of Christmas appeared first on Conduct Science.
            BioSapien Inc - How a Career in Life Sciences Is Lucrative and Rewarding?
            The post How a Career in Life Sciences Is Lucrative and Rewarding? appeared first on Conduct Science.
              Celsius Therapeutics - Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer
              PARIS, France and CAMBRIDGE, Mass., US – December 21st, 2020 – Servier, a global pharmaceutical Group, and Celsius Therapeutics, a company focused on bringing precision medicine to patients with cancer and autoimmunity, today announced a strategic collaboration focused on the identification and...
                Cue Biopharma - Associate Director / Director Preclinical Development
                Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. Cue Biopharma is a high grow...
                  EpigenCare - Epigenetic Company EpigenCare Debuts $99 Version of its SKINTELLI Personalized Skincare DNA Test
                  FARMINGDALE, N.Y., December 23, 2020 —EpigenCare Inc., a biotechnology company specializing in consumer epigenetics, launched its new version of its SKINTELLI personalized skincare test. The product, which is a direct-to-consumer DNA test, looks at the current quality of an individual’s skin ...
                    Evelo Biosciences - Evelo Biosciences Appoints Industry Veteran Jonathan Zung, Ph.D. as Chief Development Officer
                      Genomenon - Mastermind CNV Search
                      The Mastermind Genomic Search Engine now includes searching by Copy Number Variation (CNV). This new feature accelerates the diagnosis and interpretation of results for patients with genetic disease. Here’s how to find CNVs in Mastermind. Mastermind identifies every gene, variant, disease, phen...
                        Grail - AJMC, Novel Multicancer Early Detection Technology—Potential Value to Employers and the Workforce
                        The post AJMC, Novel Multicancer Early Detection Technology—Potential Value to Employers and the Workforce appeared first on 
                          IsoPlexis - IsoPlexis & PhenoVista Biosciences Partner to Provide Access to a Comprehensive Range of Cellular Assay Technologies
                          PhenoVista Biosciences Named Certified Service Provider of IsoPlexis’ Functional Proteomics Technology PhenoVista Biosciences, a privately-owned service-based biosciences company based out of San Diego, has been named an IsoPlexis Certified Service Provider. PhenoVista Biosciences is now certif...
                            Kyndi - Could Unsupervised Learning be THE Key to Enterprise AI Adoption?
                            84% of Enterprise AI projects have not scaled – is supervised learning the problem? By Ryan Welsh, Founder & CEO, Kyndi Enterprise AI requires a new AI approach. That is our belief here at Kyndi, and that was a central theme at NeurIPS 2020, which was held virtually from December 6th &...
                              Mindleap Health - Psychedelic Integration – What, Why, and How
                              It is well accepted at this point that psychedelics are capable of producing deeply moving experiences that can catalyze one’s personal healing and overall growth. Well-intentioned use with respect to set and setting can yield a beneficial shift in perspective and even change our entire world-v...
                                Nurix - Senior IT System Administrator
                                The ideal candidate will help Nurix evolve a secure, robust environment for users to do their work, no matter where they are working. The ideal candidate will have a diverse background that includes infrastructure, support experience, vendor management skills and experience with MSPs (Managed Ser...
                                  Oculogica - Oculogica Adds to IP Portfolio with Patent for Glaucoma
                                  Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.  
                                    Omniome - OMNIOME ANNOUNCES KELLY PEREZ AS CHIEF OPERATING OFFICER
                                    An experienced leader in corporate development and operations steps into new role at growing start-up SAN DIEGO- November 20, 2020- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, announces the promotion of Kelly Perez to Ch...
                                      Owkin - Transfer Learning in Healthcare: Tackling the Curse of Dimensionality
                                      Clinical healthcare datasets are an expensive prerequisite for conducting medical research with machine learning. Comprised of rare pathologies, these datasets are often smaller in sample size and can be hard to acquire. Discover how this machine learning technique, alongside Owkin technologies, ...
                                        Paradromics - Neurotech Pub Episode 3
                                        						Paradromics CEO Matt Angle speaks with Stuart Cogan, Vanessa Tolosa, Thomas Steiglitz, and Loren Reith about how to protect neural implants from the harsh environment of the body. 
                                          Pheronym - 8 experts identify the biggest hurdles to feeding a warming world
                                          Dr. Kaplan our CEO is among 8 experts identify the biggest hurdles to feeding a warming world featured by C&EN magazine Discovery Report Feeding the world. You can download the report at www.acs.org/discoveryreports.
                                            Q32 Bio - Q32 Bio Appoints Experienced Biopharmaceutical Leader Mark Iwicki as Chairman of Board of Directors
                                            Cambridge, Mass. (December 22nd, 2020) – Q32 Bio, a biotechnology company developing therapeutics to restore healthy immune regulation, today announced the appointment of industry leader Mark Iwicki as Chairman of their Board of Directors. Mr. Iwicki will succeed Dr. David Grayzel as Chairman. ...
                                              Rain Therapeutics - Kolbot By
                                              Kolbot By is Vice President, Technical Operations and Chemical Development at Rain Therapeutics. He has over 25 years of experience in synthetic organic chemistry, solid-state chemistry, development and manufacturing of small molecules, late-stage development and validation, QbD-enabling CMC...
                                                RegeneRx - RegeneRx Issues Year End Letter To Stockholders
                                                Update on Phase 3 Clinical Trials and Near Term Operations
                                                  RenovaCare - RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
                                                  Roseland, NJ – December 22, 2020 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that it has issued the following year-end...
                                                    SafeTraces - Verifying Engineering Controls: The Critical Role of Emerging Technology
                                                    Featured in the AIHA Blog Written by Erik Malmstrom, CEO of SafeTraces | December 22, 2020 2020 has been a wake-up call for […]
                                                    The post Verifying Enginee...